Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer
Clinical trial NCT04822298 · TERMINATED
Trial details
- NCT number
- NCT04822298
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2021-12-08
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.